Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-3-15
pubmed:abstractText
Postmenopausal hormone therapy increases mammographic density, a strong breast cancer risk factor, but effects vary across women. We investigated whether the effect of hormone therapy use is modified by polymorphisms in the estrogen receptor (ESR1) and progesterone receptor (PGR) genes in the Dutch Prospect-EPIC and the English EPIC-Norfolk cohorts. Information on hormone therapy use was obtained through questionnaires at recruitment and after 5 years. Blood samples were collected and consecutive mammograms were available through breast cancer screening programs. For 795 hormone therapy users, one mammogram before and a second mammogram during hormone therapy use was included. For 781 never hormone therapy users, mammograms with similar time intervals were included. Mammographic density was assessed using a computer-assisted method. Changes in density were analyzed using linear regression. A statistically significant difference in percentage density change between hormone therapy users and never users was seen in women with the ESR1 PvuII Pp or pp genotype (2.24%; P < 0.01), but not in those with the PP genotype (0.90%; P = 0.47). Similarly, effects of hormone therapy on percentage density were observed in women with the ESR1 XbaI Xx or xx genotype (2.20%; P < 0.01), but not in those with the XX genotype (-0.65%; P = 0.70). Also, effects were seen in women with the PGR +331 GG genotype (2.04%; P < 0.01), but not in those with the GA or AA genotype (0.98%; P = 0.53). The PGR PROGINS polymorphism did not seem to make women more susceptible to the effects of hormone therapy use. In conclusion, our results suggest that specific polymorphisms in the ESR1 and PGR genes may make women more susceptible to the effects of hormone therapy use on mammographic density.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1055-9965
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
462-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16537702-Aged, pubmed-meshheading:16537702-Breast Neoplasms, pubmed-meshheading:16537702-Case-Control Studies, pubmed-meshheading:16537702-DNA, Neoplasm, pubmed-meshheading:16537702-Estrogen Receptor alpha, pubmed-meshheading:16537702-Female, pubmed-meshheading:16537702-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16537702-Genotype, pubmed-meshheading:16537702-Great Britain, pubmed-meshheading:16537702-Hormone Replacement Therapy, pubmed-meshheading:16537702-Humans, pubmed-meshheading:16537702-Linear Models, pubmed-meshheading:16537702-Mammography, pubmed-meshheading:16537702-Middle Aged, pubmed-meshheading:16537702-Netherlands, pubmed-meshheading:16537702-Polymorphism, Genetic, pubmed-meshheading:16537702-Postmenopause, pubmed-meshheading:16537702-Probability, pubmed-meshheading:16537702-Prognosis, pubmed-meshheading:16537702-Prospective Studies, pubmed-meshheading:16537702-Receptors, Progesterone, pubmed-meshheading:16537702-Risk Assessment, pubmed-meshheading:16537702-Tumor Markers, Biological
pubmed:year
2006
pubmed:articleTitle
Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
pubmed:affiliation
Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Mail-drop Str. 6.131, P.O. Box 85500, 3508 GA Utrecht, the Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't